Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road.
作者信息
Miller Andrew H, Raison Charles L
机构信息
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.
University of Arizona College of Medicine, Tucson.
出版信息
JAMA Psychiatry. 2015 Jun;72(6):527-8. doi: 10.1001/jamapsychiatry.2015.22.
Abstract
摘要
相似文献
1
Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road.抗炎疗法是精神疾病的可行治疗方法吗？：理论与实践的结合点
JAMA Psychiatry. 2015 Jun;72(6):527-8. doi: 10.1001/jamapsychiatry.2015.22.
2
New Approaches for the Treatment of Mental Disorders Comorbid with Inflammatory Diseases.
Curr Top Med Chem. 2020;20(15):1342-1343. doi: 10.2174/156802662015200601093328.
3
Nicotine for psychiatric disease: from nuisance to novel treatment?用于精神疾病的尼古丁：从麻烦到新型治疗手段？
Future Med Chem. 2015;7(10):1217-20. doi: 10.4155/fmc.15.67.
4
Neuroinflammation and cognition across psychiatric conditions.神经炎症与各种精神疾病中的认知功能障碍。
CNS Spectr. 2019 Feb;24(1):4-15. doi: 10.1017/S1092852918001499. Epub 2019 Feb 4.
5
The hygiene hypothesis and psychiatric disorders.卫生假说与精神疾病。
Trends Immunol. 2008 Apr;29(4):150-8. doi: 10.1016/j.it.2008.01.002. Epub 2008 Mar 6.
6
Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations.欧米伽-3脂肪酸二十碳五烯酸。一种治疗精神疾病和神经退行性疾病的新疗法：临床研究综述。
Expert Opin Investig Drugs. 2007 Oct;16(10):1627-38. doi: 10.1517/13543784.16.10.1627.
7
Research on psychiatric disorders targets inflammation.针对精神疾病的研究以炎症为目标。
JAMA. 2014 Aug 6;312(5):474-6. doi: 10.1001/jama.2014.8276.
8
Acetylsalicylic acid and its metabolite gentisic acid may act as adjunctive agents in the treatment of psychiatric disorders.乙酰水杨酸及其代谢产物龙胆酸可能作为辅助药物用于治疗精神疾病。
Behav Pharmacol. 2019 Dec;30(8):627-641. doi: 10.1097/FBP.0000000000000517.
9
[Analgesic and anti-inflammatory drug prescriptions and number of radiograms predict antidepressant treatment: study of reimbursement data from the Provence health insurance fund].
Presse Med. 2007 Jan;36(1 Pt 1):50-6. doi: 10.1016/j.lpm.2006.07.004. Epub 2006 Dec 11.
10
Advances in pediatric pharmacology, toxicology, and therapeutics.
Adv Pediatr. 1999;46:507-38.
引用本文的文献
1
Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.推进精准精神病学与靶向治疗：免疫精神病学的见解
Brain Behav Immun. 2025 Mar;125:319-329. doi: 10.1016/j.bbi.2025.01.002. Epub 2025 Jan 17.
2
Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation.重度抑郁症的转录组学特征：免疫代谢和细胞周期相关通路在不同炎症水平抑郁症中的作用
Mol Psychiatry. 2025 Apr;30(4):1308-1318. doi: 10.1038/s41380-024-02736-w. Epub 2024 Sep 13.
3
Heart-Brain Axis: A Narrative Review of the Interaction between Depression and Arrhythmia.心脑轴：抑郁症与心律失常相互作用的叙述性综述
Biomedicines. 2024 Aug 1;12(8):1719. doi: 10.3390/biomedicines12081719.
4
TNF-α/TNFR1 activated astrocytes exacerbate depression-like behavior in CUMS mice.肿瘤坏死因子-α/肿瘤坏死因子受体1激活的星形胶质细胞会加剧慢性不可预知轻度应激小鼠的抑郁样行为。
Cell Death Discov. 2024 May 6;10(1):220. doi: 10.1038/s41420-024-01987-4.
5
Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study.重度抑郁症患者的免疫相关基因表达较高，与 CRP 水平无关：BIODEP 研究结果。
Transl Psychiatry. 2023 Jun 1;13(1):185. doi: 10.1038/s41398-023-02438-x.
6
PKR-like ER kinase (PERK) Haplotypes Are Associated with Depressive Symptoms in People with HIV.蛋白激酶R样内质网激酶（PERK）单倍型与HIV感染者的抑郁症状相关。
J Neurol Psychol. 2023;10(1). doi: 10.13188/2332-3469.1000049. Epub 2023 Mar 9.
7
Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign.炎症增加与抑郁症治疗：从耐药到再利用、重新定位和重新设计
Adv Neurobiol. 2023;30:387-416. doi: 10.1007/978-3-031-21054-9_16.
8
Anti-inflammatory properties of commonly used psychiatric drugs.常用精神科药物的抗炎特性。
Front Neurosci. 2023 Jan 10;16:1039379. doi: 10.3389/fnins.2022.1039379. eCollection 2022.
9
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.烧毁房屋：重塑精神病学药物研发以开发靶向疗法。
Mol Psychiatry. 2023 Jan;28(1):68-75. doi: 10.1038/s41380-022-01887-y. Epub 2022 Dec 2.
10
Towards a multidimensional model of inflamed depression.迈向炎症性抑郁症的多维模型。
Brain Behav Immun Health. 2022 Nov 20;26:100564. doi: 10.1016/j.bbih.2022.100564. eCollection 2022 Dec.
本文引用的文献
1
Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.抗炎治疗对抑郁、抑郁症状和不良反应的影响：随机临床试验的系统评价和荟萃分析。
JAMA Psychiatry. 2014 Dec 1;71(12):1381-91. doi: 10.1001/jamapsychiatry.2014.1611.
2
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.炎症生物标志物作为依他普仑与去甲替林治疗抑郁症结局的差异预测指标。
Am J Psychiatry. 2014 Dec 1;171(12):1278-86. doi: 10.1176/appi.ajp.2014.14010094. Epub 2014 Oct 31.
3
National Institute of Mental Health clinical trials: new opportunities, new expectations.美国国立精神卫生研究所临床试验：新机遇，新期望。
JAMA Psychiatry. 2014 Jul 1;71(7):745-6. doi: 10.1001/jamapsychiatry.2014.426.
4
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.一项针对肿瘤坏死因子拮抗剂英夫利昔单抗治疗抵抗性抑郁症的随机对照试验：基线炎症生物标志物的作用。
JAMA Psychiatry. 2013 Jan;70(1):31-41. doi: 10.1001/2013.jamapsychiatry.4.
5
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.心理神经免疫学与神经精神药理学的交汇：炎症对行为影响的转化意义。
Neuropsychopharmacology. 2012 Jan;37(1):137-62. doi: 10.1038/npp.2011.205. Epub 2011 Sep 14.
6
Immune modulation of learning, memory, neural plasticity and neurogenesis.学习、记忆、神经可塑性和神经发生的免疫调节。
Brain Behav Immun. 2011 Feb;25(2):181-213. doi: 10.1016/j.bbi.2010.10.015. Epub 2010 Oct 21.
7
Loss of cadherin-11 adhesion receptor enhances plastic changes in hippocampal synapses and modifies behavioral responses.钙黏蛋白-11黏附受体的缺失会增强海马体突触的可塑性变化并改变行为反应。
Mol Cell Neurosci. 2000 Jun;15(6):534-46. doi: 10.1006/mcne.2000.0849.
Zotero 插件